Gabelli Utility Trust (The) (GUT) Ratings GUT Home News Ratings Charts Dividends Gabelli Utility Trust (The) (GUT): $5.49 0.03 (+0.55%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum NR Stability NR Sentiment Get Rating Quality NR Add GUT to Watchlist Sign Up Industry: Asset Management Industry NR Ranked #NR of 64 in industry See All 'A' Rated Buy Stocks Gabelli Utility Trust (The) (GUT) Ratings History Chart Free access to the full ratings history for GUT. Sign up now! Gabelli Utility Trust (The) (GUT) Ratings History Table Date Symbol POWR Rating Growth Value Momentum Quality Stability Sentiment Industry 2021-02-13 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-12 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-11 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-10 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-09 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-08 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-07 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-05 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-04 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-03 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! 2021-02-02 GUT Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Unlock Now! Most Popular Stories View All • Updated 2024 Stock Market Outlook • Top 4 Tech Giants Poised for Explosive Growth • 3 Top Rated Software Stocks to Streamline Your Investments • Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)? • Investor Alert: “Buy the Rumor, Sell the News!” View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe